Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Story1
Eli Lilly discloses 5,480,872-share stake in TRex Bio after IPO allocation
A Schedule 13D filed by Eli Lilly and Company on 16 October 2026 shows the drugmaker holds 5,480,872 shares of TRex Bio, Inc., built from preferred-stock conversions and an IPO purchase, with a Lilly employee sitting on TRex Bio's board.
Company or person29
TRex Bio, Inc.
Company
TREX CO INC
Company
TELA Bio, Inc.
Company
GRI Bio, Inc.
Company
Q32 Bio Inc.
Company
Instil Bio, Inc.
Company
KALA BIO, Inc.
Company
Inmune Bio, Inc.
Company
BiomX Inc.
Company
Upstream Bio, Inc.
Company
BELITE BIO, INC
Company
Climb Bio, Inc.
Company
Korro Bio, Inc.
Company
BIOVIE INC.
Company
BIOGEN INC.
Company
Valion Bio, Inc.
Company
KYNTRA BIO, INC.
Company
Adicet Bio, Inc.
Company
iBio, Inc.
Company
BioAtla, Inc.
Company
CEMTREX INC
Company
Annovis Bio, Inc.
Company
Passage BIO, Inc.
Company
ADAPTIN BIO, INC.
Company
MUSTANG BIO, INC.
Company
IN8BIO, INC.
Company
Tron Inc.
Company
BioCorRx Inc.
Company
BIOLARGO, INC.
Company